Serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination.

Yuta MyojinHayato HikitaYuki TahataAkira DoiSeiya KatoYoichi SasakiKumiko ShiraiSadatsugu SakaneRyoko YamadaTakahiro KodamaHideki HagiwaraYasuharu ImaiNaoki HiramatsuShinji TamuraKeiji YamamotoKazuyoshi OhkawaTaizo HijiokaHiroyuki FukuiYoshinori DoiYukinori YamadaTakayuki YakushijinEiji MitaRyotaro SakamoriTomohide TatsumiTetsuo Takehara

Published in: Alimentary pharmacology & therapeutics (2021)

Serum GDF15 predicts de novo HCC occurrence. Scoring using GDF15, AFP, and the FIB-4 index can predict de novo HCC occurrence risk after HCV elimination.

Keyphrases

hepatitis c virus
risk assessment
human immunodeficiency virus
liver fibrosis
hiv infected